Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

NCT07262983 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

NIH

Sponsor class

Conditions

Hyper IgE Syndrome From STAT3 Mutation
Job s Syndrome
HIES
Lupus
Atopic Dermatitis

Interventions

DRUG: baricitinib

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)